Interim data from phase 2 KYSA-6 study, using KYV-101 for the treatment of patients with Myasthenia Gravis, expected 2nd half ...

The eThekwini ANC regional chair, former mayor and corruption accused has said she would not wish the step-aside rule even on ...

US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...

Feedback, a Lego fan, delves into a new science-related set, and learns that the model of a DNA double helix is the wrong way ...

The image, shared on X (formerly Twitter) by the handle "Indian History Pics," showcases a bygone era with neatly parked ...

New research suggests that changes in alcohol consumption significantly impact cholesterol levels, raising questions about ...

Immunovant said on Wednesday its drug for a type of a chronic autoimmune disease that causes muscle weakness met the main goal in a late-stage trial.

One of four survivors who was trapped inside the cabin of a motorized boat that crashed near Outer Harbour Marina in 2022 recalls the panic and fear she experienced that night.

Lorundrostat demonstrated strong efficacy and safety in the pivotal Phase 3 Launch-HTN and Phase 2 Advance-HTN trials. These ...

While this pembrolizumab-based regimen is promising and much needed in this patient population, one should remain cognizant of its high costs and the subsequent impact this may have on patients and ...

All-female team explores a promising compound against this ‘essentially incurable’ disease Society has no shortage of metaphors for cancer. Oncologist Siddhartha Mukherjee famously titled his ...